# Optimization of Melatonin Administration in Healthy Adults

> **NCT07514507** · NA · NOT_YET_RECRUITING · sponsor: **IRCCS Fondazione Stella Maris** · enrollment: 14 (estimated)

## Conditions studied

- Sleep Disorders

## Interventions

- **DIETARY_SUPPLEMENT:** Mel 2 mg 30 min
- **DIETARY_SUPPLEMENT:** Mel 2 mg 3 h
- **DIETARY_SUPPLEMENT:** Mel 4 mg 30 min
- **DIETARY_SUPPLEMENT:** Mel 4 mg 3 h
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07514507
- **Lead sponsor:** IRCCS Fondazione Stella Maris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07514507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07514507, "Optimization of Melatonin Administration in Healthy Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07514507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*